Clinical trials in bipolar mania: implications in study design and drug development.
Tohen
Mauricio
M
Lilly Research Laboratories, Eli Lilly Corporate Center, Indianapolis, IN 46285, USA. m.tohen@lilly.com
D001714:Bipolar Disorder / Q000188:drug therapy*; D018450:Disease Progression; D015195:Drug Design; D006801:Humans; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D012107:Research Design; D013629:Tamoxifen / Q000627:therapeutic use
D047428:Protein Kinase Inhibitors; D013629:Tamoxifen